🚀

JNJ Johnson & Johnson

Health Care > Pharmaceuticals, Biotechnology & Life Sciences > Pharmaceuticals > Pharmaceuticals  | NYSE, MegaCap |  Last Price: 248.43 | 2026-02-27 | Atrp: 1.57

Sat 21 Feb 2026 to Fri 27 Feb 2026: Score 5

MetricPreviousNewChangeInterpretation
✅Price Book MRQ7.2975.7077▼ -21.78%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue6.61265.2941▼ -19.94%Bullish. Lower is better. Moderate improvement
Enterprise value divided by revenue
✅Enterprise Value/EBITDA15.171313.4597▼ -11.28%Bullish. Lower is better. Moderate improvement
Enterprise value to earnings before interest, taxes, depreciation
✅Short Ratio2.162.11▼ -2.31%Bullish. Lower is better. Slight improvement
❌Short Percent0.81%0.86%▲ 6.17%Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
❌Enterprise Value$622.86B$479.78B▼ -22.97%Bearish. Higher is better. Decreased, reflecting lower market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sat 14 Feb 2026 to Sat 21 Feb 2026: Score 11

MetricPreviousNewChangeInterpretation
✅PEG Ratio1.32451.0724▼ -19.03%Bullish. Lower is better. Moderate decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Forward PE21.186416.4204▼ -22.5%Bullish. Lower is better. Significant improvement
Stock price divided by expected future earnings
✅Operating Margin TTM22.99%23.97%▲ 4.26%Bullish. Higher is better. Operating margin TTM growth accelerating.
Percentage of revenue left after operating expenses
✅Return On Assets TTM8.26%8.68%▲ 5.08%Bullish. Higher is better. Return on assets TTM growth accelerating.
Efficiency in generating profits from total assets
✅EBITDA$33059.66M$33836M▲ 2.35%Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow
Earnings before interest, taxes, depreciation, and amortization
✅Book Value32.94733.865▲ 2.79%Bullish. Higher is better. Slight increase; stock now trades closer to book value
Net asset value of the company per share
❌Return On Equity TTM35.56%35.03%▼ -1.49%Bearish. Higher is better. Return on equity TTM growth slowing.
Efficiency in generating profits from shareholders' equity

Sat 07 Feb 2026 to Sat 14 Feb 2026: Score 6

MetricPreviousNewChangeInterpretation
✅Enterprise Value/EBITDA23.446615.0328▼ -35.88%Bullish. Lower is better. Significant improvement
Enterprise value to earnings before interest, taxes, depreciation
✅Short Ratio2.622.16▼ -17.56%Bullish. Lower is better. Moderate improvement
✅Short Percent0.89%0.81%▼ -8.99%Bullish. Lower is better. Slight decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short
✅Enterprise Value$600.14B$617.17B▲ 2.84%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
❌PEG Ratio1.28791.3245▲ 2.84%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE20.618621.1864▲ 2.75%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Sales TTM6.13856.2286▲ 1.47%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Enterprise Value/Revenue6.37146.5522▲ 2.84%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue

Sat 31 Jan 2026 to Sat 07 Feb 2026: Score -19

MetricPreviousNewChangeInterpretation
❌Enterprise Value/EBITDA13.459723.4466▲ 74.2%Bearish. Lower is better. Substantial decline
Enterprise value to earnings before interest, taxes, depreciation
❌Forward PE16.420420.6186▲ 25.57%Bearish. Lower is better. Significant decline
Stock price divided by expected future earnings
❌Price Book MRQ5.70777.2266▲ 26.61%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌PEG Ratio1.07241.2879▲ 20.1%Bearish. Lower is better. Significant increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Enterprise Value/Revenue5.29416.3714▲ 20.35%Bearish. Lower is better. Significant decline
Enterprise value divided by revenue
❌Price Sales TTM5.81276.1385▲ 5.6%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Enterprise Value$574.84B$600.14B▲ 4.4%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash

Sat 24 Jan 2026 to Sat 31 Jan 2026: Score 14

MetricPreviousNewChangeInterpretation
✅Enterprise Value/EBITDA21.785213.4597▼ -38.22%Bullish. Lower is better. Significant improvement
Enterprise value to earnings before interest, taxes, depreciation
✅PEG Ratio1.19951.0724▼ -10.6%Bullish. Lower is better. Moderate decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Forward PE19.193916.4204▼ -14.45%Bullish. Lower is better. Moderate improvement
Stock price divided by expected future earnings
✅Price Book MRQ6.69025.7077▼ -14.69%Bullish. Lower is better. Closer to 1; less overvalued on assets but improved perception
Stock price divided by book value per share for the most recent quarter
✅Enterprise Value/Revenue5.91995.2941▼ -10.57%Bullish. Lower is better. Moderate improvement
Enterprise value divided by revenue
✅Wall Street Target Price224.085230.6267▲ 2.92%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Enterprise Value$557.62B$574.84B▲ 3.09%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
❌Price Sales TTM5.63085.8127▲ 3.23%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Short Ratio2.552.62▲ 2.75%Bearish. Lower is better. Slight decline
❌Short Percent0.85%0.89%▲ 4.71%Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short

Sat 17 Jan 2026 to Sat 24 Jan 2026: Score 15

MetricPreviousNewChangeInterpretation
✅PEG Ratio2.9721.1995▼ -59.64%Bullish. Lower is better. Substantial decrease, improving the value relative to growth
P/E ratio adjusted for growth rate
✅Quarterly Revenue Growth YOY71%91%▲ 33.82%Bullish. Higher is better. Quarterly revenue growth YOY growth accelerating.
Year-over-year growth in quarterly revenue
✅Wall Street Target Price212.0017224.085▲ 5.7%Bullish. Higher is better. Higher analyst expectations, pointing to increased optimism for future performance
Analysts' consensus target price for the stock
✅Earnings Per Share10.3411.03▲ 6.67%Bullish. Higher is better. Slight increase in earnings per share
Profit allocated to each outstanding share
✅EPS Estimate Current Year10.808111.5342▲ 6.72%Bullish. Higher is better. Slight increase; improved outlook for current year earnings
Expected earnings per share this year
✅EPS Estimate Next Year11.497612.4894▲ 8.63%Bullish. Higher is better. Slight raised expectations for further out
Expected earnings per share next year
✅Profit Margin27.26%28.46%▲ 4.4%Bullish. Higher is better. Profit margin growth accelerating.
Percentage of revenue that turns into profit
✅Return On Equity TTM33.62%35.56%▲ 5.77%Bullish. Higher is better. Return on equity TTM growth accelerating.
Efficiency in generating profits from shareholders' equity
✅EBITDA$31922M$33059.66M▲ 3.56%Bullish. Higher is better. Increase in earnings before interest, taxes, depreciation, and amortization; indicates stronger operational cash flow
Earnings before interest, taxes, depreciation, and amortization
✅Gross Profit TTM$62988M$64115M▲ 1.79%Bullish. Higher is better. Slight increase, but margins may be improving
Revenue minus cost of goods sold over the trailing twelve months
✅Revenue TTM$92149M$94193M▲ 2.22%Bullish. Higher is better. Slight top-line expansion
Total revenue over the trailing twelve months
✅Revenue Per Share TTM38.2838.772▲ 1.29%Bullish. Higher is better. Slight improvement
Revenue generated per outstanding share over the trailing twelve months
✅Price Sales TTM5.7175.6308▼ -1.51%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
✅Enterprise Value/Revenue6.01255.9199▼ -1.54%Bullish. Lower is better. Slight improvement
Enterprise value divided by revenue
❌Operating Margin TTM30.2%22.99%▼ -23.87%Bearish. Higher is better. Operating margin TTM growth slowing.
Percentage of revenue left after operating expenses
❌Quarterly Earnings Growth YOY911%491%▼ -46.59%Bearish. Higher is better. Quarterly earnings growth YOY growth slowing.
Year-over-year growth in quarterly earnings
❌Enterprise Value/EBITDA13.926421.7852▲ 56.43%Bearish. Lower is better. Substantial decline
Enterprise value to earnings before interest, taxes, depreciation

Sat 10 Jan 2026 to Sat 17 Jan 2026: Score -8

MetricPreviousNewChangeInterpretation
❌PEG Ratio2.78682.972▲ 6.65%Bearish. Lower is better. Slight increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
❌Forward PE17.889119.084▲ 6.68%Bearish. Lower is better. Slight decline
Stock price divided by expected future earnings
❌Price Sales TTM5.34395.717▲ 6.98%Bearish. Lower is better. Higher multiple; market willing to pay more per dollar of sales
Stock price divided by revenue per share over the trailing twelve months
❌Price Book MRQ6.25296.6453▲ 6.28%Bearish. Lower is better. Further to 1; more overvalued on assets but worsened perception
Stock price divided by book value per share for the most recent quarter
❌Enterprise Value/Revenue5.6756.0125▲ 5.95%Bearish. Lower is better. Slight decline
Enterprise value divided by revenue
❌Enterprise Value/EBITDA13.144613.9264▲ 5.95%Bearish. Lower is better. Slight decline
Enterprise value to earnings before interest, taxes, depreciation
❌Short Ratio2.462.55▲ 3.66%Bearish. Lower is better. Slight decline
✅Enterprise Value$522.95B$554.05B▲ 5.95%Bullish. Higher is better. Increased, reflecting higher market cap and possibly debt adjustments
Market capitalization plus debt minus cash
✅Short Percent1%0.85%▼ -15%Bullish. Lower is better. Moderate decrease; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short

Sat 03 Jan 2026 to Sat 10 Jan 2026: Score -4

MetricPreviousNewChangeInterpretation
❌PEG Ratio1.11772.7868▲ 149.33%Bearish. Lower is better. Extreme increase, worsening the value relative to growth
P/E ratio adjusted for growth rate
✅Price Sales TTM5.42135.3439▼ -1.43%Bullish. Lower is better. Lower multiple; market willing to pay less per dollar of sales
Stock price divided by revenue per share over the trailing twelve months

Sun 21 Dec 2025 to Sat 03 Jan 2026: Score 1

MetricPreviousNewChangeInterpretation
✅Short Ratio2.632.46▼ -6.46%Bullish. Lower is better. Slight improvement
❌Short Percent0.99%1%▲ 1.01%Bearish. Lower is better. Slight increase; still high, potential for squeeze if positive catalysts emerge
Percentage of shares sold short